You are here

RSVpreF

Pfizer's maternal RSV vaccine filing gets priority review, setting up showdown with AstraZeneca, Sanofi

Pfizer's maternal RSV vaccine filing gets priority review, setting up showdown with AstraZeneca, Sanofi

Fierce Pharma

Flag link:

Pfizer's RSV vaccine rush gets FDA boost with priority review

Pfizer's RSV vaccine rush gets FDA boost with priority review

Fierce Biotech

priority review

Flag link:

Pfizer heads to the FDA with an early lead over rivals in the $10B RSV vaccine market

Pfizer heads to the FDA with an early lead over rivals in the $10B RSV vaccine market

Endpoints

Flag link:

RSVVW 2021 – Pfizer gets maternal

RSVVW 2021 – Pfizer gets maternal

EP Vantage

Flag link:

Could This Be Pfizer's Next Blockbuster Vaccine?

Could This Be Pfizer's Next Blockbuster Vaccine?

Motley Fool

clinical trials

Flag link: